LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
37 hedge funds and large institutions have $319M invested in LianBio American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 12 closing their positions.
3% more funds holding
Funds holding: 36 → 37 (+1)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3.24% less ownership
Funds ownership: 83.39% → 80.15% (-3.2%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
42% less capital invested
Capital invested by funds: $550M → $319M (-$232M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$2.93M |
| 2 |
Citigroup
New York
|
+$2.2M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$1.04M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$321K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
+$273K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$11M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$6.96M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$3.7M |
| 4 |
BlackRock
New York
|
-$3.39M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$736K |
LIAN Hedge Fund Activity: Q1 2022 in Review
37 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q1 2022, worth a combined $319M — down 42% from $550M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new LIAN positions and 12 closed out — a net gain of 1 holder — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $2.93M. The largest seller was Deerfield Management, exiting entirely with an estimated $11M sold.
- 37 institutional investors held LianBio American Depositary Shares (LIAN) as of Q1 2022, up from 36 in Q4 2021.
- Funds reported $319M of LianBio American Depositary Shares stock for Q1 2022, down 42% quarter-over-quarter.
- 13 funds opened new LianBio American Depositary Shares positions in Q1 2022 and 12 closed out, a net change of +1 holder.
- The largest LianBio American Depositary Shares buyer in Q1 2022 was Citadel Advisors, an estimated $2.93M added.
- The largest LianBio American Depositary Shares seller in Q1 2022 was Deerfield Management, an estimated $11M sold.
Based on aggregated 13F filings for Q1 2022.